NCT01971177

Brief Summary

This clinical study is a randomized, controlled, open, prospective, multi-centre, multi-surgeon post-market-clinical-follow-up study to investigate the impact of cataract grade on the efficacy and safety of femtosecond laser assisted lens fragmentation to support phacoemulsification of the cataractous lens prior to intraocular lens (IOL) implantation.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
136

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Oct 2013

Shorter than P25 for phase_4

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

October 23, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 29, 2013

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

March 14, 2014

Status Verified

March 1, 2014

Enrollment Period

4 months

First QC Date

October 23, 2013

Last Update Submit

March 13, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effective Phacoemulsification Time

    The effective phacoemulsification time (EPT) used the "Laser group" (pooled from all grades) during phacoemulsification is lower than or equal to that in the "Manual group" (pooled from all grades); p\<0.05 will be considered statistically significant.

    This criterion should be achieved at the day of treatment.

Secondary Outcomes (1)

  • Adverse Events

    This purpose criterion should be achieved intraoperative, at 1 day, 1 week and 1 month.

Study Arms (2)

Femtosecond laser cataract surgery

EXPERIMENTAL

"Laser group": a pre-fragmentation of the ocular lens will be performed by VICTUS femtosecond laser lens fragmentation procedure.

Device: Femtosecond laser cataract surgery

Manual cataract surgery

ACTIVE COMPARATOR

"Manual": manual group acts as a control group where the lens fragmentation are performed manually without femtosecond laser assisted lens fragmentation

Procedure: Manual cataract surgery

Interventions

The VICTUS lens fragmentation procedure is part of the femtosecond laser assisted cataract procedure, which generates precise cuts inside the cataractous lens, leading to a softening and fragmentation of the lens. The correct positioning of the cuts inside the lens can be verified by means of an optical coherence tomograph (OCT) before starting the laser assisted fragmentation process. Various surgical patterns will be used within this study. For each pattern different geometry/laser parameters can be adjusted individually according to each patient's cataract status. All the patients who are enrolled in the laser groups (all cataract grades) will be treated with femtosecond laser assisted capsulotomy before the femtosecond laser assisted lens fragmentation by VICTUS femtosecond laser platform.

Femtosecond laser cataract surgery

"Manual": manual group acts as a control group where the lens fragmentation are per-formed manually without femtosecond laser assisted lens fragmentation

Manual cataract surgery

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have read, understood and signed the Patient Information
  • Patients are willing and able to return for follow-up examinations
  • Clear corneal media
  • Cataract grade (nuclear) from I to V according to LOCS III
  • Patients must be at least 40 years of age

You may not qualify if:

  • Patients presenting a clear lens (clear lens exchange)
  • Glaucoma and suspected glaucoma
  • Patients with pre-existing proliferative diabetic retinopathy (mild and tight controlled diabetes symptoms, without retinopathy and non-proliferative diabetic retinopathy, can be included.)
  • Retinal disorders
  • Rheumatic diseases
  • Occlusion of retinal vessels
  • Pellucid marginal degeneration
  • Herpes zoster or herpes simplex keratitis
  • Heavy vascularization of the ocular tissue
  • Epilepsy
  • Recurrent corneal erosion
  • Severe basement membrane disease
  • Patients who suffer from severe wound-healing disorders such as connective tissue disease, autoimmune illnesses, immunodeficiency illnesses,endocrine diseases, lupus, rheumatoid arthritis, collagenosis, or clinically significant atopy
  • Patients suffering from AIDS or HIV.
  • Chemosis
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gemini Eye Clinic

Zlín, 76001, Czechia

Location

MaxiVision Laser Centre Private Limited

Hyderabad, 500082, India

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Pavel Stodulka, Dr. med

    Gemini clinic, Zlin, Czech Republic 76001

    PRINCIPAL INVESTIGATOR
  • Kasu Prasad Reddy, MD

    MaxiVision Laser Centre Private Limited, Hyderabad, India

    PRINCIPAL INVESTIGATOR
  • N Sreelakshmi, MD

    MaxiVision Laser Centre Private Limited, Hyderabad, India

    PRINCIPAL INVESTIGATOR
  • Stephen Slade, MD

    Slade & Baker Vision Center

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2013

First Posted

October 29, 2013

Study Start

October 1, 2013

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

March 14, 2014

Record last verified: 2014-03

Locations